Company Filing History:
2 out of 41 
1 out of 439 
1 out of 16,080 Years Active: 1990-1998
Title: Innovations by Soldano Ferrone
Introduction
Soldano Ferrone is a notable inventor based in Scarsdale, NY (US). He has made significant contributions to the field of medical research, particularly in the development of monoclonal antibodies for the treatment of melanoma. With a total of 4 patents, Ferrone's work has the potential to impact cancer treatment significantly.
Latest Patents
Ferrone's latest patents include innovative approaches to utilizing antidiotypic monoclonal antibodies for melanoma treatment. One of his inventions focuses on murine antiidiotypic monoclonal antibodies that serve as internal images of determinants recognized by monoclonal antibodies on high molecular weight-melanoma associated antigen (HMW-MAA). This invention encompasses antibody derivatives, hybridoma cell lines that secrete these antibodies, and processes for their preparation. These antibodies are instrumental in determining the presence of antibodies directed against HMW-MAA, modulating the immune response, and treating melanoma. Another patent involves the antiidiotypic monoclonal antibodies MK2-23 and anti-melanomal antibody 763.74, which share similar applications and benefits in melanoma treatment.
Career Highlights
Throughout his career, Soldano Ferrone has worked with esteemed organizations such as New York Medical College and Suntory Limited. His experience in these institutions has allowed him to advance his research and contribute to significant medical innovations.
Collaborations
Ferrone has collaborated with notable professionals in his field, including Masashi Matsui and Suresh C Srivastava. These collaborations have further enriched his research and development efforts.
Conclusion
Soldano Ferrone's contributions to the field of melanoma treatment through his innovative patents highlight his role as a significant inventor in medical research. His work continues to pave the way for advancements in cancer therapies.